Inventor · disambiguated record
Daljit S. Dhanoa
Also filed as: DHANOA DALJIT · DHANOA DALJIT S · DHANOA DALJIT SINGH
34 granted patents·2 pending applications·665 citations·filing 1991–2024
97Inventor score
Files withMERCK & CO INC15DHANOA DALJIT SINGH11DIMENSIONAL PHARM INC4SYNAPTIC PHARMA CORP3AGOURON PHARMA1
Top patents by PatentIndex Score
36 records- 0196US6391877B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted May 21, 2002·52 cites·39 claims
- 0295US5334598ASix-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted Aug 2, 1994·101 cites·8 claims
- 0394US6211241B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·58 cites·11 claims
- 0493US11634428B2Deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitorsDHANOA DALJIT SINGH·Filed 2021·Granted Apr 25, 2023·2 cites·10 claims
- 0591US5668176APhenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1996·Granted Sep 16, 1997·59 cites·14 claims
- 0688US8927553B2Deuterium-enriched alkyl sulfonamides and uses thereofDHANOA DALJIT SINGH·Filed 2013·Granted Jan 6, 2015·6 cites·20 claims
- 0788US5264439AQuinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl elementMERCK & CO INC·Filed 1991·Granted Nov 23, 1993·38 cites·8 claims
- 0887US5565485ABiphenyl compounds useful or endothelin antagonistsMERCK & CO INC·Filed 1994·Granted Oct 15, 1996·32 cites·23 claims
- 0984US5449682AAngiotensin II antagonists incorporating a substituted benzyl elementMERCK & CO INC·Filed 1993·Granted Sep 12, 1995·28 cites·11 claims
- 1082US6506784B1Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticidesDIMENSIONAL PHARM INC·Filed 2000·Granted Jan 14, 2003·14 cites·17 claims
- 1182US5183810AImidazole angiotensin II antagonists incorporating a substituted benzyl elementMERCK & CO INC·Filed 1991·Granted Feb 2, 1993·26 cites·8 claims
- 1280US6518266B11- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticidesDIMENSIONAL PHARMACEUTICALS 3·Filed 2000·Granted Feb 11, 2003·17 cites·41 claims
- 1380US5240938AAngiotensin II antagonists incorporating a substituted pyridoimidazolyl ringMERCK & CO INC·Filed 1991·Granted Aug 31, 1993·23 cites·13 claims
- 1477US5177095ATriazole angiotensin II antagonists incorporating a substituted benzyl elementMERCK & CO INC·Filed 1991·Granted Jan 5, 1993·19 cites·9 claims
- 1574US9453027B2Deuterium-enriched pyridinonecarboxamides and derivativesDHANOA DALJIT SINGH·Filed 2013·Granted Sep 27, 2016·1 cites·6 claims
- 1674US6409988B1Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligandsDIMENSIONAL PHARM INC·Filed 2000·Granted Jun 25, 2002·4 cites·16 claims
- 1773US5151435AAngiotensin ii antagonists incorporating an indole or dihydroindoleMERCK & CO INC·Filed 1991·Granted Sep 29, 1992·30 cites·10 claims
- 1872US8530479B2Deuterium-enriched alkyl sulfonamidesDHANOA DALJIT SINGH·Filed 2010·Granted Sep 10, 2013·2 cites·7 claims
- 1970US5374638ASix membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthmaMERCK & CO INC·Filed 1993·Granted Dec 20, 1994·40 cites·6 claims
- 2069US5420133AQuinazolinones substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted May 30, 1995·39 cites·14 claims
- 2169US2025179026A1Deuterium-Enriched 3,5-Dimethylpyrazolyl-3-propoxy-4-fluorobenzoic Acids for Treatment of Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) and Polyneuropathy (ATTR-PN), and Related DiseasesDHANOA DALJIT SINGH·Filed 2024·Application pending·0 cites
- 2268US9271979B2Deuterium-enriched pyrimidine compounds and derivativesDHANOA DALJIT SINGH·Filed 2011·Granted Mar 1, 2016·1 cites·20 claims
- 2368US8557994B2Deuterium-enriched pyridinonecarboxamides and derivativesDHANOA DALJIT SINGH·Filed 2010·Granted Oct 15, 2013·1 cites·5 claims
- 2467US2025163026A1Deuterium-Enriched Nirmatrelvir as SARS-CoV-2 Mpro Inhibitor for the Treatment of COVID-19DHANOA DALJIT SINGH·Filed 2023·Application pending·0 cites
- 2566US6545033B1Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticidesDIMENSIONAL PHARM INC·Filed 2000·Granted Apr 8, 2003·3 cites·21 claims
- 2665US5401745AQuinazolinones substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted Mar 28, 1995·10 cites·10 claims
- 2764US7060706B1QuinazolinonesDIMENSIONAL PHARM INC·Filed 2000·Granted Jun 13, 2006·3 cites·8 claims
- 2863US6469021B1Non-peptide antagonists of GLP-1 receptor and methods of useAGOURON PHARMA·Filed 1999·Granted Oct 22, 2002·23 cites·18 claims
- 2963US5767310APhenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1994·Granted Jun 16, 1998·8 cites·3 claims
- 3055US5254682ACyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogsMERCK & CO INC·Filed 1991·Granted Oct 19, 1993·13 cites·15 claims
- 3154US12458624B2Deuterium-enriched substituted phenoxyphenyl acetic acids and acylsulfonamidesDHANOA DALJIT SINGH·Filed 2020·Granted Nov 4, 2025·0 cites·1 claims
- 3254US6713580B2Quaternary amino acids on solid supportsPHARMACORE INC·Filed 2001·Granted Mar 30, 2004·1 cites·67 claims
- 3354US5175164AAngiotensin ii antagonists incorporating a substituted indole or dihydroindoleMERCK & CO INC·Filed 1991·Granted Dec 29, 1992·11 cites·12 claims
- 3449US6734182B2Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Granted May 11, 2004·0 cites·25 claims
- 3543US9271980B2Deuterium-enriched pyrimidine compounds and derivativesDHANOA DALJIT SINGH·Filed 2012·Granted Mar 1, 2016·0 cites·19 claims
- 3639US8618116B2Deuterium-enriched pyrimidine compounds and derivativesDHANOA DALJIT SINGH·Filed 2010·Granted Dec 31, 2013·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Daljit S. Dhanoa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →